Bionovo Inc logo

Bionovo Inc

$ 0.00 0 (0%) 09:42 AM EST
At Loss
Market Cap:
$ 300.00K
Enterprise V:
$ -
Avg Vol (2M):
Market Cap $:
PE Ratio:
At Loss
Avg Vol (2M):
Enterprise Value $:
PB Ratio:

Business Description

Bionovo Inc was originally incorporated in California in February of 2002. In March of 2004, it re-incorporated in the state of Delaware and in June of 2005 changed its name from Bionovo, Inc. to Bionovo Biopharmaceuticals, Inc. On April 6, 2005, Bionovo Biopharmaceuticals, Inc. became public through a reverse merger with Lighten Up International, Inc., whereby Lighten Up Enterprises International, Inc. acquired all the outstanding shares of Bionovo Biopharmaceuticals, Inc. in exchange for restricted shares of its common stock in a reverse triangular merger. The acquisition was accounted for as a reverse merger in which Bionovo Biopharmaceuticals, Inc. was deemed to be the accounting acquirer. The Company operated as Lighten Up Enterprises International, Inc. until June 29, 2005 when the Company assumed the name Bionovo, Inc. The Company is a clinical stage drug discovery and development company engaged in women's health and cancer. The Company's drug candidate, Menerba, represents a new class of receptor sub-type selective estrogen receptor modulator for the treatment of vasomotor symptoms of menopause, or hot flashes. It has designed Menerba to selectively modulate estrogen receptor beta and to provide a safe and effective alternative to existing FDA approved therapies that pose a significant risk to women for developing breast cancer, stroke, cardiovascular disease, blood clots and other serious diseases. In preclinical studies, Menerba does not to the tumor formation in either breast or uterine tissues and it does not increase the risk for clotting. The Company is also developing Bezielle, an oral anticancer agent for advanced breast cancer. Bezielle is designed to take advantage of a metabolism of cancer cells, with a well-characterized mechanism of action for selective tumor cell DNA damage and the death of cancer cells, without lasting harm to normal cells. It has a pipeline of additional preclinical drug candidates in both women's health and cancer. The Company has internally discovered and developed all of its drug candidates using its proprietary biological and chemical techniques. Its drug development process uses herbs and other botanical sources, used in Traditional Chinese Medicine, and believed to produce biologically active compounds. It applies its clinical knowledge, experience with natural compounds and knowledge of proper scientific screening tools to isolate and purify botanical compounds and extracts for pharmaceutical development.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

How Bionovo Inc (BNVIQ) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:BNVIQ

Peter Lynch Chart

Y-axis scale:
Interactive Chart



Annualized Return %

1 Week
1 Month
3 Months
6 Months
1 Year
3 Years
5 Years
10 Years

Total Annual Return %




Valuation chart


Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.265
EPS (TTM) ($) -0.26
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0.0003 - 0.02
Shares Outstanding (Mil) 80.33

Piotroski F-Score Details

Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bionovo Inc Filings

Document Form Filing Date
No Filing Data

Bionovo Inc Stock Events

Event Date Price($)
No Event Data

Bionovo Inc Frequently Asked Questions

What is Bionovo Inc(BNVIQ)'s stock price today?
The current price of BNVIQ is $0.00. The 52 week high of BNVIQ is $0.02 and 52 week low is $0.00.
When is next earnings date of Bionovo Inc(BNVIQ)?
The next earnings date of Bionovo Inc(BNVIQ) is .
Does Bionovo Inc(BNVIQ) pay dividends? If so, how much?
Bionovo Inc(BNVIQ) does not pay dividend.

Press Release

Subject Date
No Press Release


See More
  • 1
No news.
  • 1